Indrayani Biotec — 360° view

Indrayani Biotec, a company in the Other Agricultural Products industry, reported revenue of ₹38 crore and net profit of ₹0.54 crore for the June 2026 quarter.

Indrayani Biotec (BSE: INDRANIB) closed at ₹8.87 on 20 Nov 2026, down 37.8% over the past year. Its market capitalisation is ₹69 crore and it trades at 33.9 times earnings.

Share price
₹8.87 (20 Nov 2026)
Market cap
₹69 Cr (20 Nov 2026)
P/E
33.94 (20 Nov 2026)
Revenue
₹38 Cr (June 2026 quarter)
Net profit
₹1 Cr (June 2026 quarter)
ROCE
4.24% (FY26)
ROE
2.97% (FY26)
Book value
₹16.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹15.60 / ₹6.10 (20 Nov 2026)
1-year return
-37.8% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Other Agricultural Products
Symbol
BSE: INDRANIB

Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.